Moderna’s Shift to Cancer Company Lifts Stock Up 177%
NYT > Health
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
تحميل تطبيق نبأ للآندرويد مجانا
اقرأ على الموقع الرسمي

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
تحميل تطبيق نبأ للآندرويد مجانا